Skip to content
Innovative Tech
Diseases
Health Policy
HTA
Data Analysis
Clinical Practice
Contributors
BACK TO MAIN SITE
Cost Savings on Generic Drugs: Transparent Pric...
By
HEOR Staff Writer
June 18, 2024
Introduction Through its transparent, online direct-to-consumer pharmacy model, the Mark Cuban Cost Plus Drug Company (MCCPDC) has made substantial progress in the provisi...
Introducing GRACE for Patient-Centric Care
Universal Early Parenting Programmes: Unraveling the Cost-Effectiveness
Rethinking Health State Valuation: Moving Beyond ‘Dead’ as an Anchor
Healthcare Decision-Making with MCDA Framework: The Saudi Arabian Perspective
Balancing the scales: An inclusive framework for equity in Multi-Cancer Early...
How User-Centered Perspectives Foster Innovation in Digital Health Surveillan...
Treatment Effect Estimation with AI: The CURE Framework
Pay-for-Performance in Brazilian Healthcare: Success and Impact
Medical AI Future: Sustainable Reimbursement Strategies
Economics in Clinical Trials: A Guide to Value-Based Decisions
A Cost-Effectiveness Analysis of Emicizumab Treatment in Non-Severe Haemophil...
Innovative Technology Policy: Simulation Modelling in Healthcare
« Previous
1
…
6
7
8
9
10
…
12
Next »